Roadzen (NASDAQ:RDZN – Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.04) EPS for the quarter, Zacks reports.
Roadzen Trading Down 2.3 %
Shares of Roadzen stock traded down $0.03 on Thursday, reaching $1.26. The stock had a trading volume of 52,173 shares, compared to its average volume of 318,392. The business’s 50 day moving average is $1.79 and its two-hundred day moving average is $1.44. Roadzen has a 1 year low of $0.71 and a 1 year high of $6.99. The company has a market cap of $93.48 million, a P/E ratio of -0.66 and a beta of 0.21.
Analysts Set New Price Targets
RDZN has been the topic of a number of recent research reports. ThinkEquity began coverage on Roadzen in a research report on Monday, October 28th. They set a “buy” rating and a $6.00 price target on the stock. Maxim Group lowered their price target on shares of Roadzen from $7.00 to $4.00 and set a “buy” rating on the stock in a research report on Friday, November 15th.
Roadzen Company Profile
Roadzen, Inc, an insurtech company, provides various insurance products in the United States and internationally. It offers insurance as a service platform, including Via, which enables fleets, carmakers, and insurers to inspect a vehicle using computer vision; Global Distribution Network that enables the configuration, customer quote, payment, and administration of any insurance policy with any insurance carrier as the underwriter; xClaim, which enables digital, touchless, and real-time resolution of claims; StrandD, a digital, real-time dispatch, and tracking for roadside assistance and first notice of loss during accident claims; Good Driving that enables insurers and fleets to recognize drivers, train drivers, and build usage based insurance programs; and Drivebuddy AI, which provides driver-assistance capabilities.
Read More
- Five stocks we like better than Roadzen
- What is the S&P/TSX Index?
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- How to Use the MarketBeat Dividend Calculator
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
- The Basics of Support and Resistance
- CVS Health: Earnings Beat Ignites Stock Rally
Receive News & Ratings for Roadzen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roadzen and related companies with MarketBeat.com's FREE daily email newsletter.